Hala models this across three Saudi supply-chain profiles, using one formula set and pathway-specific defaults for stock requirement, gross margin, gateway exposure and carrying cost. The defaults below are the guideline figures in Hala's Hormuz Cost Impact Calculator — a SAR150m annual-turnover, SAR120m annual-affected-supply-value business in each pathway. Your own turnover, volumes and margins will differ; use the calculator to run your actual numbers.
The financing rate behind every figure
Every pathway is financed at 12-month SAIBOR plus a bank margin. 12-month SAIBOR ran in the high-4% range through the first half of 2026 — 4.83% on 6 May and 4.91% on 11 June, per GIB Capital's daily market reports — giving a practical funding range of roughly SAIBOR + 150 to 350 basis points, or approximately 6.3% to 8.3% per year, depending on the bank and the facility. Full carrying cost — the APQC-defined total of cost of capital, storage, insurance, handling, administration, shrinkage and obsolescence — sits in a widely used industry planning range of 20% to 30% of inventory value annually for standard goods, rising to 25% to 40% for cold chain, dangerous goods, expiry-sensitive stock and slow-moving specialist spares.
The three profiles
| Pathway | Required stock | Total annual cost impact | % of turnover | % of gross profit consumed | Margin risk | Cash risk | Route risk |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Petrochem / oilfield | 6 months | SAR 36.6m | 24.4% | 162.9% | Critical | High | Critical |
| Pharma government supplier | 6 months | SAR 31.0m | 20.7% | 115.0% | Critical | High | Critical |
| Industrial | 2 months | SAR 17.5m | 11.7% | 58.5% | Critical | Moderate | Moderate |
|~ Guideline defaults: SAR150m annual turnover, SAR120m annual affected supply value, per Hala's Hormuz Cost Impact Calculator. Total impact includes freight, inland transport, storage, inflation and risk cost, plus the incremental carrying cost of stock above the current 1-month baseline.
The 'gross profit consumed' column is the sharpest way to read this table. On the petrochemical and pharma pathways, the modelled cost exceeds the entire annual gross profit the business generates — meaning the exposure is not a margin dent, it is margin-negative before anything else in the business is accounted for. Even the industrial pathway, with a shorter two-month stock requirement, consumes well over half of gross profit.
Six-month Saudi stock is the core cost driver on the petrochem and pharma pathways — the container surcharge most suppliers are watching is a fraction of the real number.